Thermo Fisher Scientific (TMO)
$480.17 1.82 (0.38%)
19:58 EDT TMO Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 193.18B
PE Ratio 85.29
Volume (Avg. Vol.) 1.16M
Day's Range 473.49 - 483.71
52-Week Range 250.21 - 485.00
Dividend & Yield 0.66 (0.14%)
TMO Stock Predictions, Articles, and Thermo Fisher Scientific News
- From InvestorPlace
- From the Web
The novel coronavirus has upended the existing economic order. These seven innovative stocks will reap the rewards of these changes.
TMO stock is expensive. However, the company is of extremely high quality, making it a worthwhile purchase whenever the market corrects.
Friday's big stock charts feature three large-cap names that have found a bottom — and which could keep rallying, particularly with outside help.
We saw equities fall in the stock market today, despite the Federal Reserve stepping up with an emergency 50-basis-points rate cut.
Politicians have investors in healthcare stocks nervous as the 2020 election nears. Here's a guide to which firms are good choices and which you should avoid.
Nanotech stocks cover a broad range of industries as their underlying innovation impacts all corners of business and society.
One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.
Thermo Fisher (TMO) will shell out $1.7 billion to buy Brammer Bio in order to continue the company's progress in the gene therapy field.
Stock charts of Thermo Fisher Scientific, Intuit Intercontinental Exchange have all earned a closer inspection here.
Add these names to a list of stocks to buy sooner rather than later. Between seasonality and news, these tickers could buck the marketwide bearish trend.
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. TMO has maintained this ranking for 2 months.
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
The current recommendation of Buy for Thermo Fisher Scientific Inc (NYSE:TMO) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Thermo Fisher Scientific Inc (NYSE:TMO) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, with a market value of $74.7 billion. From an investment attractiveness prospective, TMO is ranked in the top half of the sector with a ranking of 311 among the 782 companies in the sector; the ranking for TMO by Portfolio Grader places it 20 among the 33 companies in this industry group, giving it a lower than average position and number 1,957 in the 5000 company Portfolio Grader company universe.
From Talk Markets
From Talk Markets
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader